Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-17T04:36:31.881Z Has data issue: false hasContentIssue false

Chapter 27 - Male menopause – similarities and differences with the female menopause

Published online by Cambridge University Press:  05 September 2015

By
Malcolm E. Carruthers
Edited by
Nick Panay ,
Paula Briggs  and
Gab Kovacs
Nick Panay
Affiliation:
Queen Charlotte’s Hospital, London
Paula Briggs
Affiliation:
Sefton Community Sexual Health Service, Liverpool
Gab Kovacs
Affiliation:
Monash University, Victoria
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Managing the Menopause
21st Century Solutions
 , pp. 223 - 231
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sheehy, G. The Silent Passage. London: HarperCollins; 1991.Google Scholar
Carruthers, M. The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action. J Sex Med 2008; 5: 998–1012.CrossRefGoogle Scholar
Wolfe, SM. Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosterone. Br Med J 2014; 348: g1789.CrossRefGoogle ScholarPubMed
Hall, SA, Ranganathan, G, Tinsley, LJ, et al. Population-based patterns of prescription androgen use, 1976–2008. Pharmacoepidemiol Drug Saf 2014; 23: 498–506.CrossRefGoogle ScholarPubMed
Morgentaler, A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol 2013; 189: S26–33.CrossRefGoogle ScholarPubMed
Feneley, MR, Carruthers, M. Is testosterone treatment good for the prostate? Study of safety during long-term treatment. J Sex Med 2012; 9: 2138–49.CrossRefGoogle ScholarPubMed
Khera, M, Crawford, D, Morales, A, Salonia, A, Morgentaler, A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014; 65: 115–23.CrossRefGoogle ScholarPubMed
Stanworth, R, Jones, T. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Frontiers Horm Res 2009; 37: 74–90.CrossRefGoogle ScholarPubMed
Jones, TH, Arver, S, Behre, HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: 828–37.CrossRefGoogle ScholarPubMed
Perheentupa, A, Mäkinen, J, Laatikainen, T, et al. A cohort effect on serum testosterone levels in Finnish men. Eur J Endocrinol 2013; 168: 227–33.CrossRefGoogle ScholarPubMed
Basaria, S, Coviello, AD, Travison, TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109–22.CrossRefGoogle ScholarPubMed
Vigen, R, O'Donnell, CI, Barón, AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310: 1829–36.CrossRefGoogle ScholarPubMed
Jones, TH, Channer, KS. Deaths and cardiovascular events in men receiving testosterone. JAMA 2014; 311: 961–5.CrossRefGoogle ScholarPubMed
Traish, AM, Guay, AT, Morgentaler, A. Death by testosterone? We think not! J Sex Med 2014; 11: 624–9.CrossRefGoogle Scholar
Finkle, WD, Greenland, S, Ridgeway, GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE 2014; 9: e85805.CrossRefGoogle ScholarPubMed
Morgentaler, A. Testosterone, cardiovascular risk, and hormonophobia. J Sex Med 2014; 11: 1362–6.CrossRefGoogle ScholarPubMed
Moskovic, DJ, Araujo, AB, Lipshultz, LI, Khera, M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med 2013; 10: 562–9.CrossRefGoogle ScholarPubMed
Arver, S, Luong, B, Fraschke, A, et al. Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden. J Sex Med 2013; Aug 12. [Epub ahead of print]. PubMed PMID: 23937088.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×